Skip to main content
ADCT
NYSE Life Sciences

ADC Therapeutics Restructures: $86.6M PIPE, $70M Debt Paydown, HCR Royalty Rework

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.82
Mkt Cap
$237.462M
52W Low
$0.78
52W High
$4.98
52W Position info
133% above low
Off High info
63% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

ADCT has more than doubled off its 52-week low of $0.78.

Summary

ADC Therapeutics announced a $86.6M PIPE, $70M debt paydown, and HCR royalty agreement amendments that extend cash runway into 2029 but add ~61M shares of potential dilution.


Key Events · Financing and Capital Events · ADCT

  • $86.6M PIPE at Deep Discount

    12.9M common shares at $1.42 plus pre-funded warrants for 48.1M shares at $1.324, raising $86.6M gross. Pricing is well below the $1.82 share price at the time of this report.

  • Massive Potential Dilution

    Combined 61M new shares (12.9M common + 48.1M warrant shares) represent roughly 2.6x the current ~23.5M share count implied by the $237.5M market cap at $1.82.

  • Debt Restructured to $50M Bullet

    $70M term-loan prepayment reduces principal to $50M, eliminates minimum liquidity covenant, and defers all amortization to August 2029 maturity.

  • HCR Change-of-Control Payment Eliminated

    The $150M payment triggered by a change of control is removed, replaced by a buyout option of $525M (before 2030) or $750M (after 2030), less royalties already paid.


Analysis · ADCT · Life Sciences

A comprehensive balance-sheet overhaul materially changes ADC Therapeutics' capital structure and survival runway. The $86.6M PIPE at $1.42 per share — a deep discount to the $1.82 price at the time of this report — combined with a $70M term-loan prepayment and elimination of the minimum liquidity covenant removes near-term covenant pressure. The HCR amendment eliminates a $150M change-of-control payment that would have made any acquisition prohibitively expensive, and reprices 9.8M HCR warrants from $3.81 to $0.10, creating significant future dilution. The company now projects cash runway into 2029, up from prior concerns, but the cost is substantial: roughly 61M new shares (12.9M common + 48.1M pre-funded warrants) against a market cap of only ~$237M. This is a survival financing that keeps the company alive to reach LOTIS-7 and MZL data readouts in December, but existing shareholders absorb heavy dilution.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 49.5% of the 210 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ADCT was trading at $1.82 on NYSE in the Life Sciences sector, with a market capitalization of approximately $237.5M. The 52-week trading range was $0.78 to $4.98. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADCT - Latest Insights

ADCT
Nov 09, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.75
Real-time Price: $1.42 info
Change: -$0.3263 (-19%) info
Market Cap: $180.011M info
ADCT
Nov 09, 2026, 7:30 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.42 info
Change: -$0.1603 (-10%) info
Market Cap: $180.011M info
ADCT
Nov 04, 2026, 4:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.72
Real-time Price: $1.42 info
Change: -$0.3003 (-17%) info
Market Cap: $180.011M info
ADCT
Nov 03, 2026, 5:02 PM EST
Filing Type: S-4
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.42 info
Change: -$0.1303 (-8%) info
Market Cap: $180.011M info
ADCT
Oct 08, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.33
Real-time Price: $1.42 info
Change: +$0.0897 (+7%) info
Market Cap: $180.011M info